How many mg is 90 units of tirzepatide?

Step 1, The maths behind the conversion

Tirzepatide in clinical preparations follows a concentration of 8 mg per ml. An insulin syringe divides 1 ml into 100 units, meaning each unit equals 0.01 ml of solution. Multiply 90 units by 0.01 ml and you get 0.9 ml. Multiply 0.9 ml by 8 mg/ml and the result is 7.5 mg.

It is a question our prescribers hear most weeks, usually from people who have seen tirzepatide discussed in a clinical context or who are curious about how the pen dose maps onto a syringe measurement. The short answer is clean: 90 units, 7.5 mg, no ambiguity.

For reference, if you want to check adjacent doses: the reverse calculation for 7.5 mg confirms that 93.75 units would technically deliver 7.5 mg at this concentration, which is why pen-based delivery at a fixed pre-set volume is far more practical than drawing from a vial for home use. Rounding errors in unit measurements can become clinically meaningful.

The BNF tirzepatide monograph details the preparation concentrations for prescribers and pharmacists, and is the professional reference point for these figures.

Step 2, Where 7.5 mg sits in the licensed titration schedule

Tirzepatide treatment starts at 2.5 mg, and if you are curious how many units that starting dose works out to, the answer follows from the same 8 mg/ml concentration logic covered above. That first four-week period is about settling the body into the medicine, the initial dose is a tolerability step, not where the therapeutic effect is felt most. From there, doses typically increase through 5 mg, then 7.5 mg, then 10 mg, 12.5 mg and finally 15 mg, with at least four weeks between each increase.

So 7.5 mg sits at the third rung of the dose ladder. Many people find the side-effect profile becomes more manageable by this stage, as the body has had time to adjust across two prior dose steps. Others stay at 7.5 mg as their maintenance dose if that level achieves good results with good tolerability. There is no single correct stopping point, that judgement belongs to your prescriber.

If you are exploring what the different strengths involve, the 5 mg dose page explains the step that precedes 7.5 mg, and for anyone who wants to understand how many units 5 mg of tirzepatide represents, that calculation is covered in detail there. For a broader view of how Mounjaro works across all strengths, the Mounjaro overview covers the full picture.

Titration timing, whether to stay at a dose or move up, and what to do if a dose is missed, all of these are decisions for your prescriber and the Patient Information Leaflet, not for a unit-conversion table.

Step 3, Why home users never count units

Mounjaro KwikPens are engineered so patients never touch a syringe. Each pen contains enough solution for four once-weekly injections at the pen's labelled strength. You dial to the dose marker, inject, and the pen delivers the correct volume automatically. There is no vial, no syringe, no unit counting.

Unit measurements become relevant in two situations: when a pharmacist or clinician is working with a multi-dose vial (uncommon for tirzepatide in UK primary care), or when someone is cross-checking whether a dose discussed in a clinical note corresponds to a pen strength they recognise. That is a legitimate and sensible thing to want to know.

What it is not is a route to self-adjusting your own dose. Knowing that 90 units equals 7.5 mg does not mean switching to the 7.5 mg pen yourself, that step requires a prescriber's assessment and, at nume, an evidence-based review before any dose increase is approved.

For context on what treatment through a regulated UK pharmacy involves, the weight-loss treatment overview explains how clinical oversight works at each stage. And if cost is on your mind at this point in your research, the Mounjaro cost page sets out what private treatment typically involves.

Getting the right dose for you

The conversion is straightforward. Whether 7.5 mg is the right dose for a specific person is a different question entirely, one that depends on how they have responded to earlier doses, their current weight, any side effects they have experienced, and their overall health picture.

At nume, every dose increase is reviewed by a GPhC-registered Independent Prescriber before it proceeds. A real clinician reads the information, not software. That applies to the very first prescription and to every repeat order thereafter. If you have questions about your specific situation before starting a consultation, our FAQs cover the most common ones, or you can get in touch directly.

When you are ready, check your eligibility through our free consultation, it takes a few minutes and is reviewed the same day.